Aeterna Zentaris presents positive data from AEZS-108 Phase 2 study in ovarian tumor at ASCO 2010 Encouraging trend observed in overall survival Aeterna Zentaris Inc Read more . , , a late-stage drug development organization specific in endocrine and oncology therapy, announced that it offered positive efficacy and security data for its doxorubicin targeted conjugate compound today, AEZS-108, in ovarian cancer. The demonstration was made by Prof. AEZS-108 is currently in a Phase 2 trial conducted in Europe by the German AGO Research Group , in advanced ovarian and endometrial cancer tumor, with benefits expected by year-end.
Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus Aethlon Medical, Inc. The research were performed by alternative party experts approved by america Department of Health and Human Solutions to house and conduct research on the current pandemic strains of H1N1 virus. At present, the 2009 2009 H1N1 influenza virus may be the predominant influenza virus in circulation generally in most countries worldwide.